Although numerous drugs have been associated with increased Beclin-1 activity, including tamoxifen, Beclin-1 expression mimetics (BH3 mimetics) and the peptide Tat-Beclin-1, only few studies tested pharmacological Beclin-1 stimulation in PD models [139–141]. This evidence concerns the gene BECN1 and Parkinson disease.